Jeena Sikho Lifecare Limited — Investor Meet, 12-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Jeena Sikho Lifecare reported strong financial results for Q2 FY26. Revenue grew 66% YoY to Rs. 190 Cr, with PAT jumping 121% YoY to Rs. 59 Cr and EBITDA rising 129% YoY to Rs. 92 Cr, achieving a 48% EBITDA margin. The company reached its 2,800-bed target ahead of schedule, with 57% occupancy, aiming for 70-80%. Strategic tie-ups like Chandan Diagnostics and plans to launch 10 new OTC products by FY26 end are key growth drivers. Management remains confident, targeting Rs. 650-700 Cr turnover and Rs. 125-130 Cr PAT for FY26, maintaining 20-25% PAT margins.